CRA was retained by the respondent in an ICC arbitration in which the claimant alleged an inappropriate termination of a supply agreement relating to material used in a vaccine. CRA’s analysis demonstrated that changes in the commercial market circumstances for the final product had eroded the returns to untenable levels, showing that it would be in neither party’s interests to maintain the supply agreement.
Damages in Life Sciences Arbitration
In this chapter published in The Guide to Damages in International Arbitration, Gregory Bell, Andrew Tepperman, and Justin Ho provide a brief overview of...